These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7219637)

  • 1. On the mechanism of angiotensin-induced proteinuria. I. Studies in aminonucleoside nephrotic rats and in saralasin blockade.
    Bauman JW
    Nephron; 1981; 27(1):47-50. PubMed ID: 7219637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glomerular hemodynamics in rats with chronic sodium depletion. Effect of saralasin.
    Steiner RW; Tucker BJ; Blantz RC
    J Clin Invest; 1979 Aug; 64(2):503-12. PubMed ID: 457865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of aminonucleoside nephrosis on immune complex localization in autologous immune complex nephropathy in rats.
    Couser WG; Jermanovich NB; Belok S; Stilmant MM; Hoyer JR
    J Clin Invest; 1978 Mar; 61(3):561-72. PubMed ID: 147884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules.
    Keane WF; Raij L
    Lab Invest; 1985 Jun; 52(6):599-604. PubMed ID: 4010224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stable analogs of prostaglandins E1 and F2 alpha ameliorate the proteinuria of aminonucleoside-of-puromycin nephrosis in Lewis rats.
    Ulich TR; Meline JA; Ni RX; Keys M; Wu CH
    Am J Pathol; 1987 Oct; 129(1):133-9. PubMed ID: 3499082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-activating factor mediates angiotensin II-induced proteinuria in isolated perfused rat kidney.
    Perico N; Lapinski R; Konopka K; Aiello S; Noris M; Remuzzi G
    J Am Soc Nephrol; 1997 Sep; 8(9):1391-8. PubMed ID: 9294830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside.
    Grond J; Weening JJ; Elema JD
    Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal function in rats with unilateral proteinuria produced by renal perfusion with aminonucleoside.
    Chandra M; Hoyer JR; Lewy JE
    Pediatr Res; 1981 Apr; 15(4 Pt 1):340-4. PubMed ID: 7220138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute reversal by saralasin of multiple intrarenal effects of angiotensin II.
    Steiner RW; Blantz RC
    Am J Physiol; 1979 Nov; 237(5):F386-91. PubMed ID: 495754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II inhibition on blood pressure and renal hemodynamics in pregnant rats.
    Baylis C; Collins RC
    Am J Physiol; 1986 Feb; 250(2 Pt 2):F308-14. PubMed ID: 3511733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the charge and size selectivity barrier of the glomerular filter in aminonucleoside nephrosis in rats.
    Olson JL; Rennke HG; Venkatachalam MA
    Lab Invest; 1981 Mar; 44(3):271-9. PubMed ID: 7464051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased glomerular thromboxane synthesis as a possible cause of proteinuria in experimental nephrosis.
    Remuzzi G; Imberti L; Rossini M; Morelli C; Carminati C; Cattaneo GM; Bertani T
    J Clin Invest; 1985 Jan; 75(1):94-101. PubMed ID: 4038407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noninvasive microscopic evaluation of the intact living nephrotic kidney.
    Pulver M; Petroll WM; Andrews PM
    Lab Invest; 1993 May; 68(5):592-6. PubMed ID: 8497129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats.
    Gómez-Chiarri M; Ortíz A; Lerma JL; López-Armada MJ; Mampaso F; González E; Egido J
    Lab Invest; 1994 Apr; 70(4):449-59. PubMed ID: 8176885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasoregulatory hormones and the hyperfiltration of diabetes.
    Bank N; Lahorra MA; Aynedjian HS; Schlondorff D
    Am J Physiol; 1988 Feb; 254(2 Pt 2):F202-9. PubMed ID: 2449821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irreversible tubulointerstitial damage associated with chronic aminonucleoside nephrosis. Amelioration by angiotensin I converting enzyme inhibition.
    Diamond JR; Anderson S
    Am J Pathol; 1990 Dec; 137(6):1323-32. PubMed ID: 2260622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased oxidative stress and apoptosis in acute puromycin aminonucleoside nephrosis.
    Rincon J; Romero M; Viera N; Pedreañez A; Mosquera J
    Int J Exp Pathol; 2004 Feb; 85(1):25-33. PubMed ID: 15113391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
    Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
    J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
    Garin EH; Boggs KP; Burke FC
    Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats.
    Trachtman H; Zavilowitz B; Bennett B; Goldsmith DI
    Pediatr Res; 1985 Aug; 19(8):828-34. PubMed ID: 3898001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.